← SynDRA

NEMORUBICIN

SynDRA canonical compound SYN0024236 — structure-anchored drug synonym record

All known targets

• TOP1
• TOP2A
• TOP2A; TOP2B

Mechanisms of action (all sources)

• topoisomerase inhibitor
• Modulator

Cross-references

• PubChem CID: 65907
• ChEMBL: CHEMBL1232279
• ChEBI: 42053
• PDB: DMM
• TTD: D0K2CR

Synonyms

• Nemorubicine
• Nemorubicina
• Nemorubicinol
• FCE-23762
• PNU-152243
• PNU-156685
• PNU-156686
• PNU-159682
• Nemorubicin [INN]
• Methoxymorpholino-doxorubicin
• methoxymorpholinyl-doxorubicin
• Fce 23762
• CHEBI:42053
• 7618O47BQM
• 3'-DESAMINO-3'-(2-METHOXY-4-MORPHOLINYL)-DOXORUBICIN
• (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-[(2S)-2-methoxymorpholin-4-yl]-alpha-L-lyxo-hexopyranoside
• (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 2,3,6-trideoxy-3-((S)-2-methoxymorpholino)-alpha-L-lyxo-hexopyranoside
• 3'-deamino-3'-(2-methoxymorpholin-4-yl)doxorubicin
• methoxymorpholinoDX
• Methoxymorpholinyldoxorubicin
• methoxy-morpholinyl-doxorubicin
• UNII-7618O47BQM
• SCHEMBL24646
• NEMORUBICIN [WHO-DD]
• 3'-deamino-3'-(2(S)-methoxy-4-morpholinyl)doxorubicin
• CHEMBL1232279
• DTXSID6057619
• PNU152243A
• AMY10326
• PNU-152243A
• ZINC49757291
• CS-2020
• HY-15794
• A14363
• A855698
• Q27120450
• Methoxymorpholinyldoxorubicin;PNU-152243;PNU 152243;PNU152243;PNU-152243A
• (1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 2,3,6-TRIDEOXY-3-((S)-2-METHOXYMORPHOLINO)-.ALPHA.-L-LYXO-HEXOPYRANOSIDE
• (8S,10S)-6,8,11-Trihydroxy-10-(((2R,4S,5S,6S)-5-hydroxy-4-((S)-2-methoxymorpholino)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione